ID8 Cells
USD$650.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The ID8 cell line is a widely utilized murine model derived from spontaneous transformation of C57BL/6 mouse ovarian surface epithelial (MOSE) cells. This cell line closely mimics human epithelial ovarian cancer, making it a vital tool for preclinical research into ovarian cancer pathophysiology and treatment. ID8 cells are known for their ability to grow intraperitoneally in immunocompetent C57BL/6 mice, facilitating studies of tumor progression and metastasis. This model is particularly relevant for examining peritoneal tumor formation and ascites development, which are key features of advanced ovarian cancer in patients. ID8 cells exhibit the capability to form tumors when injected intraperitoneally, leading to disseminated cancer throughout the abdominal cavity and ascitic fluid accumulation. These properties enable the exploration of tumor-host interactions, including the role of the immune system and tumor microenvironment in cancer progression. In studies involving immunotherapies or combined treatment approaches, ID8 has proven valuable for evaluating the effects of interventions such as chemotherapy agents like carboplatin and immune checkpoint inhibitors targeting PD-L1. Research involving ID8 models has shown their utility in examining the influence of tumor metabolism on immune cell behavior, particularly macrophage polarization and function. For instance, tumors induced by ID8 cells can modulate the metabolism of peritoneal macrophages, altering their oxidative phosphorylation (OXPHOS) and promoting tumor growth through metabolic crosstalk. These insights have paved the way for exploring targeted metabolic therapies that may inhibit tumor-promoting immune cell adaptations. |
|---|---|
| Organism | Mouse |
| Tissue | Ovary |
| Disease | Normal |
| Synonyms | ID-8, ID8/MOSEC |
Characteristics
| Breed/Subspecies | C57BL/6 |
|---|---|
| Age | Adult |
| Gender | Female |
| Morphology | Epithelial-like |
| Cell type | Epithelial cell |
| Growth properties | Adherent |
Regulatory Data
| Citation | ID8 (Cytion catalog number 305305) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_IU14 |
Biomolecular Data
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305305-040825 | Certificate of Analysis | 22. Oct. 2025 | 305305 |
| 305305-231024 | Certificate of Analysis | 23. May. 2025 | 305305 |